Predictive Oncology Inc Market Cap ($18.60 Million)
Market Cap & Net Worth: Predictive Oncology Inc (POAI)
Predictive Oncology Inc market cap. Predictive Oncology Inc (NASDAQ:POAI) has a market capitalization of $18.60 Million ($18.60 Million) as of November 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #25186 globally and #5343 in its home market, demonstrating a 28.64% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Predictive Oncology Inc's stock price $5.48 by its total outstanding shares 3393516 (3.39 Million). Also see how efficiently does Predictive Oncology Inc generate cash for how efficiently the company converts equity into cash flow.
Predictive Oncology Inc Market Cap History (2015–2025)
Predictive Oncology Inc market cap history from 2015 to 2025. Data shows change from $49.88 Billion to $18.60 Million (-53.49% CAGR). Check Predictive Oncology Inc share price for real-time trading data and today's change.
Index Memberships
Predictive Oncology Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.60 Trillion | 0.00% | #701 of 976 |
|
NASDAQ Composite
IXIC
|
$39.84 Trillion | 0.00% | #2307 of 3165 |
Weight: Predictive Oncology Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Predictive Oncology Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Predictive Oncology Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Predictive Oncology Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.71x
Predictive Oncology Inc's market cap is 1.71 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $49.88 Billion | $654.35K | -$4.79 Million | 76235.01x | N/A |
| 2016 | $1.90 Billion | $456.50K | -$6.53 Million | 4162.96x | N/A |
| 2017 | $685.49 Million | $654.84K | -$7.75 Million | 1046.81x | N/A |
| 2018 | $420.12 Million | $1.41 Million | -$10.09 Million | 297.61x | N/A |
| 2019 | $177.14 Million | $1.41 Million | -$19.39 Million | 125.49x | N/A |
| 2020 | $49.68 Million | $1.25 Million | -$25.88 Million | 39.67x | N/A |
| 2021 | $64.61 Million | $1.42 Million | -$19.66 Million | 45.48x | N/A |
| 2022 | $20.84 Million | $1.51 Million | -$25.74 Million | 13.84x | N/A |
| 2023 | $11.16 Million | $1.63 Million | -$13.98 Million | 6.86x | N/A |
| 2024 | $2.78 Million | $1.62 Million | -$12.20 Million | 1.71x | N/A |
Competitor Companies of POAI by Market Capitalization
Companies near Predictive Oncology Inc in the global market cap rankings as of November 3, 2026. Also see Predictive Oncology Inc total assets for a full breakdown of the balance sheet.
Key companies related to Predictive Oncology Inc by market ranking:
- Microsoft Corporation (NASDAQ:MSFT): Ranked #3 globally with a market cap of $3.65 Trillion USD.
- Palantir Technologies Inc. (NASDAQ:PLTR): Ranked #36 globally with a market cap of $407.39 Billion USD.
- Oracle Corporation (NYSE:ORCL): Ranked #45 globally with a market cap of $342.88 Billion USD.
- Palantir Technologies Inc. Class A Common Stock (NYSE:PLTR): Ranked #50 globally with a market cap of $324.25 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3 | Microsoft Corporation | NASDAQ:MSFT | $3.65 Trillion | $507.12 |
| #36 | Palantir Technologies Inc. | NASDAQ:PLTR | $407.39 Billion | $178.34 |
| #45 | Oracle Corporation | NYSE:ORCL | $342.88 Billion | $119.22 |
| #50 | Palantir Technologies Inc. Class A Common Stock | NYSE:PLTR | $324.25 Billion | $178.15 |
Market Capitalization of Predictive Oncology Inc (2015–2025)
Market capitalization of Predictive Oncology Inc from 2015 to today. Between 2015 and today, Predictive Oncology Inc's market cap moved from $49.88 Billion to $ 18.60 Million, with a yearly change of -53.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $18.60 Million | +568.29% |
| 2024 | $2.78 Million | -75.08% |
| 2023 | $11.16 Million | -46.42% |
| 2022 | $20.84 Million | -67.75% |
| 2021 | $64.61 Million | +30.05% |
| 2020 | $49.68 Million | -71.95% |
| 2019 | $177.14 Million | -57.84% |
| 2018 | $420.12 Million | -38.71% |
| 2017 | $685.49 Million | -63.93% |
| 2016 | $1.90 Billion | -96.19% |
| 2015 | $49.88 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Predictive Oncology Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.60 Million USD |
| MoneyControl | $18.60 Million USD |
| MarketWatch | $18.60 Million USD |
| marketcap.company | $18.60 Million USD |
| Reuters | $18.60 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Predictive Oncology Inc
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D cult… Read more